INFORMACIÓN BÁSICA SOBRE COOKIES

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web.
La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias.
Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso.
En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web.
Más información en el apartado POLÍTICA DE COOKIES de nuestra página web.

ACEPTAR RECHAZAR

LIST OF CLINICAL TRIALS

Search for clinical trials open in our centers by cancer type.

PLEASE MAKE A SELECTION TO
BROWSE RESULTS

OPEN TRIAL CLOSED TRIAL

BREAST CANCER

CORALEEN [OPEN TRIAL]

A Phase 2 Clinical Trial of multi-agent Chemotherapy or letrozole plus Ribociclib (LEE011) as neoadjuvant treatment for postmenopausal patients with Luminal B/HER2-negative breast cancer. Protocol: SOLTI-1402

+ INFO

LUNG AND PLEURAL CANCER

DIV-SCLC [OPEN TRIAL]

A Two-Part, Open-Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory Small Cell Lung Cancer. Protocol: DIV-301

+ INFO

SOLID TUMORS

DURVAST [OPEN TRIAL]

A phase II exploratory study of Durvalumab(MEDI4736) IN HIV-1 patients with advanced solid tumors.

+ INFO

OVARIAN CANCER

FORWARD1 [OPEN TRIAL]

A randomized, open label phase 3 study to evaluate the safety and efficacy of mirvetuximab soravtansine (IMGN853) versus investigator’s choice of chemotherapy in women with folate receptor α-positive advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

+ INFO

LUNG AND PLEURAL CANCER

G1T28-05 [OPEN TRIAL]

Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancer. Protocol: G1T28-05

+ INFO

MELANOMA, OBSERVATIONAL STUDIES

GEM-1304 [OPEN TRIAL]

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma.

+ INFO

LUNG AND PLEURAL CANCER

GO-001 [OPEN TRIAL]

A tissue acquisition study for the development of a methodology to select tumor- specific neo-antigens for the treatment of NSCLC. Protocol

+ INFO

LUNG AND PLEURAL CANCER

Imagyn050 [OPEN TRIAL]

Phase III multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab in patients with newly diagnosed ovarian, fallopian tube or primary peritoneal cancer, stage III or IV.

+ INFO

LUNG AND PLEURAL CANCER

JAVELIN 100 [OPEN TRIAL]

Phase III, open label, multicenter trial of avelumab (MSB0010718C) versus platinum doublet in first line for recurrent or stage IV PD-L1+ non-small-cell lung cancer. Protocol: EMR100070-005

+ INFO

LUNG AND PLEURAL CANCER

LINC, BR.31 [OPEN TRIAL]

Prospective, double blind, randomized phase III clinical trial, of adjuvant chemotherapy with MEDI4736 vs placebo in non-small-cell lung cancer patients following complete resection.

+ INFO